Credits: Canva
Quademic 2025: Hospitals in the United States are dealing with a surge in patients admission, the reason is the quademic it is dealing with at this moment. This has led to an influx of patients. It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.
The healthcare company founded in academics M Health Fairview, confirmed that their hospitals are overflowing due to the quademic.
The hospitals of M Health Fairview's volume is up by 30% and as a results, patients are being treated in the hallways and in alternative care areas. There is also a longer wait time and shortages for resources that are required to treat these emergencies. This has also impacted other life-threatening emergencies like heart attacks and strokes, as the healthcare resources and caregivers are occupied with the surge in seasonal cases.
ALSO READ: Birmingham Struggles With 4 Different Virus Hits, Know What They Are
Common cold and flu: The common cold and influenza (flu) are perhaps the most well-known illnesses that peak during the fall. As temperatures drop and humidity levels fluctuate, viruses that cause colds and the flu become more active. The flu, in particular, can be more severe than a common cold, leading to complications such as pneumonia, especially in vulnerable populations like the elderly and those with pre-existing health conditions. Symptoms include a runny nose, sore throat, coughing, fever, and body aches.
Covid-19: As per the World Health Organization, Coronavirus disease or COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus will experience mild to moderate respiratory illness and recover without requiring special treatment, However, there could be some cases of seriously ill patients who may require medical attention. It is also because of the other existing medical conditions like cardiovascular diseases, diabetes, chronic respiratory diseases, cancers, or older age.
The best way to protect against this virus is by following social isolation form those who are infected, using mask to prevent droplets from infecting others when you cough or sneeze and to wash your hands for 20 seconds frequently.
RSV or Respiratory Syncytial Virus: As per the Centers of Diseases Control and Prevention (CDC), RSV is a common respiratory virus that infects nose, throat and lungs. Though symptoms are similar to the viruses like flu or COVID-19, the disease in itself is different. It also peaks during the winter season, especially between December and January.
However, the main difference between RSV and other respiratory illness, above mentioned is that RSV can cause pneumonia or bronchiolitis, especially for those who are over the age of 50 or with an existing heart or lung disease.
Norovirus: It is a number 1 cause of foodborne illness in the US and this happens when virus gets into the food and then it accidentally enters your mouth. These particles are from faeces or vomit from infected people, or can be transmitted via contaminated food and water. It could also spread by touching unclean surfaces like door handles or cutlery.
For most people, having norovirus is unpleasant, but mild and recovery could be made in 1 to 2 days. However, it could be more serious for babies, older people and anyone with any existing health condition.
Credit: iStock
Twenty-six years later, the country is facing its worst outbreak of the highly contagious disease and is on the verge of losing its hard-earned elimination status.
As of November 5, 2026, the US had reported 5,182 confirmed measles cases, according to the CDC. It is the first time that the country has crossed 5,000 mark since 1991.
Further, Pennsylvania (six), New York (one) and Wisconsin (one) have reported a combined eight measles-associated deaths this year — more than the total recorded between 2000 and 2024.
The Pan American Health Organization (PAHO), a regional office of the World Health Organization, is reviewing the country's status. An announcement is expected next week.
Vaccine hesitancy is a key factor behind the resurgence, said Professor Devi Sridhar, Professor and Chair of Global Public Health at the University of Edinburgh, in an exclusive conversation with HealthandMe.
"We're seeing more parents concerned about the side effects of vaccines. Perhaps they've seen a video online or read something that makes them nervous. So for a while in the 1990s, for example, the MMR vaccine was falsely linked to rising autism rates."
She noted that while the study has since been debunked, misinformation of this kind has contributed to vaccine hesitancy, with parents choosing not to vaccinate their children despite vaccines being available because they fear potential side effects.
Two doses of the MMR vaccine are approximately 97% effective at preventing measles. Even a single dose provides strong protection, offering about 93% effectiveness.
Sridhar said the number of vaccinated children was falling below the threshold needed to prevent the virus from circulating and causing deaths in the country.
"But what we're seeing is that the number of children vaccinated is falling underneath that threshold, which is around 85 to 90%. And once you get a population that is not vaccinated to that level, measles starts to circulate, then it starts to find children, and unfortunately they get infected. And because it's so serious, we are starting to see deaths even in the United States."
Sridhar also warned that misinformation online is undermining trust in vaccines. She said online claims about the MMR vaccine, including false links to autism and fears about side effects, can discourage parents from vaccinating their children.
"That's very dangerous now because as we know, the information on the internet and on social media isn't regulated."
Read More: What Happens After Measles Infection? The Hidden Risks That Can Last For Years
Sridhar pointed to changes in the country's public health and scientific institutions over the past two years, including the dismantling of the vaccine advisory group and a shift towards alternative therapies that has contributed to vaccine hesitancy.
However, with the recent Democratic gains in Congress, she is hopeful about the possibility of restoring science in government.
“Those who are scientifically trained, those who are doctors, clinicians, PhDs, people who have that kind of background will really help to hopefully bring science back into government and into government advice and help build that trust.”
PAHO considers endemic measles transmission to have been re-established when the same virus genotype and lineage circulates uninterrupted for at least 12 months within a country or defined geographical area.
The Regional Verification Commission reviews epidemiological and laboratory evidence, alongside information on vaccination coverage, surveillance and outbreak response, before making recommendations on a country's status.
Publicly available data shows that several chains of measles transmission have continued for more than a year in the US, according to scientists who analysed the data at the request of The New York Times.
Three separate transmission chains — two in Utah and one in Arizona — were continuing in July 2026 and could be traced to an outbreak in Texas more than a year earlier. One of these chains was still circulating in Utah in September, occasionally spilling over into Oregon and Washington.
Another transmission chain, detected in Virginia at the start of the year, was still spreading in Iowa, Indiana and Pennsylvania as of mid-October.
Credit: iStock
Anthropic CEO Dario Amodei has claimed that cancer, Alzheimer's disease, heart disease and mental illness could become “relics of the past” in less than a decade, thanks to artificial intelligence (AI).
The AI company has kicked off the roadshow for its US initial public offering (IPO), seeking to raise up to $64.4 billion at a valuation of around $1 trillion. The listing could mark the first public offering by a frontier AI lab.
In the company's IPO roadshow video, Amodei spoke about AI's potential to transform human health, describing a future in which diseases that have long challenged medicine could be overcome.
"I think if we do this right, we can create an age of miracles where humanity is able to solve problems that have eluded us for millennia," he said.
Amodei also addressed the risks associated with AI and invited investors to join the company's next phase of growth.
"We have to make sure that all the risks, all the ways that things can go wrong with this technology, we very carefully address those risks as we bring the benefits, and as we have a viable business at the same time".
Amodei isn't alone. His promise is echoed by other AI leaders including Elon Musk and Google's AI boss Demis Hassabis.
However, not everybody is convinced. Cognitive scientist Gary Marcus, and cardiologist and digital medicine expert Eric Topol point out that current AI models lack the deep causal and biological understanding required to reliably yield breakthrough cures, and as of 2026, no AI-designed drug has achieved full clinical adoption.
"Setting an unattainable objective. I wish it would come true, but curing all these diseases in the next 10 years is impossible. And I'm very optimistic about the impact of AI for improving health," said Topol, in a post on X.
Marcus added that "most likely none of these will be 'relics of the past in ten years'”.
Also read: AI-Created Virus Injected Into A Human For The First Time To Fight Antibiotic Resistance
This is not the first time Amodei has spoken about AI's potential to transform healthcare. In a post on X, he wrote: “I think it will actually be possible to cure most human disease in ~5-10 years.”
In two of his essays, Amodei discussed how advanced AI could accelerate biological and medical research, potentially compressing 50–100 years of scientific progress into five to 10 years.
His predictions have covered several major health conditions, including:
He has also discussed the possibility of AI helping humans live significantly longer.
Read More: Anthropic Says Claude Blocked Bird Flu, Chikungunya Research: How AI Could Enable Biological Misuse
In September, Anthropic partnered with medical knowledge platform OpenEvidence to provide AI-powered clinical decision support to healthcare providers in dozens of low- and middle-income countries.
OpenEvidence uses peer-reviewed research and treatment guidelines to answer doctors' clinical questions, with the initiative expected to reach about 100 countries, including Uganda, Angola, Sudan, Haiti and Mongolia.
Anthropic has also announced a Claude-led discovery of a molecular machine that researchers suspect could represent a new gene-editing mechanism, highlighting AI's potential to accelerate biological research.
What Are The Ethical Risks Of Using AI In Healthcare?
READ: AI Creates 16 Viruses To Kill Drug-Resistant E. coli, Raises Biosafety Concerns
Major technology companies, including Google, are increasingly expanding their presence in healthcare through AI-powered tools and services. However, the growing use of AI in medicine also raises questions about patient safety, privacy and accountability.
The World Health Organization (WHO) has called for stronger ethical oversight of AI-related health research.
In a recent report, WHO warned that rapid advances in AI are creating challenges around privacy, bias, fairness, transparency and accountability. It said existing research ethics systems may need additional expertise to assess risks associated with AI and large datasets.
Dr Rajeev Jayadevan, former president of IMA Cochin and convener of the Research Cell, Kerala, told HealthandMe that AI-driven research, particularly when it involves large datasets crossing national borders, may require ethics committees to include experts in computer science, data ethics and bioinformatics.
“Ethics Committees by themselves will need to be upgraded to incorporate computer scientists, data ethicists, and bioinformaticians.”
WHO also said oversight should extend beyond ethics committees to researchers, funders, scientific journals, data governance bodies, professional societies and regulators.
Credit: iStock
Delhi continues to battle high PM2.5 levels, even as a new study estimates that meeting the World Health Organization's (WHO) air quality guidelines could prevent or postpone 9.4 million deaths annually across 136 low- and middle-income countries (LMICs).
Following Diwali celebrations on November 8, PM2.5 concentrations in several parts of the capital reportedly exceeded 66 times the WHO's recommended 24-hour guideline. By November 11, Delhi's AQI had improved to below 300, in the 'poor' category, after several days in the 'very poor' and 'severe' categories.
Led by University of Cambridge researchers, the modelling study also found that cleaner air could reduce disease burden, healthcare costs and productivity losses.
Also read: PM2.5 Levels 66x WHO Limit In Delhi: How Air Pollution Could Affect Children's Lung Development
Published in Environment International, the study assessed the health and economic benefits of reducing PM₂.₅ and nitrogen dioxide (NO₂) levels across 136 LMICs.
Researchers used pollution, population and health data to model the impact of meeting WHO air quality guidelines and interim targets.
The findings suggest that meeting WHO guidelines could:
Meeting PM₂.₅ guidelines could also mean fewer new cases of:
Read More: Delhi AQI Crosses 2,000 Mark After Diwali: What Happens To Your Body Within Hours Of Exposure?
The researchers also estimated substantial economic benefits from meeting PM₂.₅ guidelines.
Annual direct medical cost savings could include:
Productivity gains could reach $17.9 billion for stroke, $18.1 billion for COPD and $5.3 billion for coronary heart disease annually.
"Meeting the WHO's air quality guideline values will not be straightforward, but low- and middle-income countries have a critical opportunity to shape healthier futures as their populations grow and their cities expand," said Dr Haneen Khreis of IMS Epidemiology at Cambridge.
She called for better decisions on transport, urban planning and energy, saying these could significantly improve air quality and reduce pollution-related diseases.
Outdoor air pollution is a major environmental health risk, linked to respiratory and cardiovascular diseases, including asthma, COPD, heart disease and stroke, as well as dementia.
In 2021, the WHO revised its air quality guidelines, setting recommended limits for pollutants including PM₂.₅ and NO₂.
PM₂.₅ consists of particles measuring 2.5 micrometers or smaller. They can travel deep into the lungs. Major sources include vehicle exhaust, power plants, industrial emissions and construction dust. These particles can also form through chemical reactions in the atmosphere.
NO₂ is mainly produced by burning fossil fuels. Sources include vehicle exhaust, industrial emissions and gas stoves and heaters.
Air pollution is a particularly serious challenge in LMICs, where rapid urbanisation, economic development and increasing vehicle use have contributed to poor air quality.
© $2026 Times Horizon Private Limited